PI
DXCM icon

PineBridge Investments’s DexCom DXCM Stock Holding History

PineBridge Investments’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.69M Buy
+99,353
New +$6.62M 0.06% 226
2026
Q1 		– Sell
-41,854
Closed -$2.78M – 516
2025
Q4 		$2.78M Buy
+41,854
New +$2.71M 0.02% 304
2025
Q1 		– Sell
-45,720
Closed -$3.56M – 751
2024
Q4 		$3.56M Buy
45,720
+20,402
+81% +$1.51M 0.03% 379
2024
Q3 		$1.7M Sell
25,318
-18,096
-42% -$1.49M 0.01% 535
2024
Q2 		$4.92M Sell
43,414
-34,970
-45% -$4.42M 0.04% 308
2024
Q1 		$10.9M Buy
78,384
+6,738
+9% +$847K 0.09% 232
2023
Q4 		$8.89M Sell
71,646
-26,949
-27% -$2.75M 0.08% 224
2023
Q3 		$9.2M Buy
98,595
+23,990
+32% +$2.7M 0.1% 183
2023
Q2 		$9.59M Sell
74,605
-2,781
-4% -$336K 0.1% 188
2023
Q1 		$8.99M Buy
77,386
+10,733
+16% +$1.2M 0.1% 210
2022
Q4 		$7.55M Buy
66,653
+65,700
+6,894% +$7.21M 0.09% 217
2022
Q3 		$77K Sell
953
-9,217
-91% -$781K ﹤0.01% 527
2022
Q2 		$758K Buy
10,170
+358
+4% +$32.7K 0.01% 410
2022
Q1 		$1.25M Buy
9,812
+224
+2% +$24.5K 0.01% 448
2021
Q4 		$1.29M Buy
9,588
+8,852
+1,203% +$1.27M 0.01% 480
2021
Q3 		$101K Sell
736
-216
-23% -$27.2K ﹤0.01% 551
2021
Q2 		$102K Sell
952
-544
-36% -$52.2K ﹤0.01% 594
2021
Q1 		$134K Sell
1,496
-15,252
-91% -$1.43M ﹤0.01% 577
2020
Q4 		$1.55M Sell
16,748
-11,804
-41% -$1.05M 0.02% 451
2020
Q3 		$2.94M Buy
28,552
+572
+2% +$59.8K 0.05% 322
2020
Q2 		$2.83M Buy
+27,980
New +$2.5M 0.05% 303
2015
Q4 		– Sell
-48,728
Closed -$1.05M – 1135
2015
Q3 		$1.05M Buy
+48,728
New +$1.09M 0.04% 240

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

PineBridge Investments's DXCM Position: Q2 2026 in Review

PineBridge Investments opened a new position in DexCom (DXCM) in Q2 2026: 99,353 shares worth $6.69M. The stake represents 0.06% of the portfolio and ranks #226 among its holdings. This is a return to the name: PineBridge Investments previously reported a position in DXCM as recently as Q4 2025.

PineBridge Investments first reported a position in DXCM in Q3 2015 and has held it in 22 quarters since. The position peaked at $10.9M in Q1 2024. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • PineBridge Investments held 99,353 shares of DexCom worth $6.69M as of Q2 2026.
  • DexCom was a new PineBridge Investments position in Q2 2026.
  • DexCom made up 0.06% of PineBridge Investments's portfolio in Q2 2026, its #226 holding.
  • PineBridge Investments first reported a position in DexCom in Q3 2015 and has held it in 22 quarters since.
  • PineBridge Investments's DexCom position peaked at $10.9M in Q1 2024.
  • 973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on PineBridge Investments's 13F filing for Q2 2026, filed 14 Aug 2026.